Astrana Health Inc.

As of June 30, 2026, Astrana Health Inc. carries a market capitalization of 2.00B, placing it among publicly traded companies globally. Its enterprise value stands at 2.30B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Astrana Health Inc.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Astrana Health Inc. has 49.23M shares outstanding.

As of June 30, 2026, Astrana Health Inc. trades at a trailing price-to-earnings ratio of 52.77. The price-to-sales ratio is 0.56, and the price-to-book ratio stands at 2.75.

As of June 30, 2026, Astrana Health Inc. trades at an EV/EBITDA multiple of 16.09 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.68 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 26.18 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Astrana Health Inc. trades at an EV/FCF ratio of 19.02, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 2.30B versus a market cap of 2.00B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Astrana Health Inc. maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 163.62, indicating elevated leverage, while an interest coverage ratio of 2.43 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Astrana Health Inc. posted a return on equity (ROE) of 5.08, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 5.11 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.18, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 6.70, useful for judging operating efficiency across full business cycles. The company generates approximately 1.23M in revenue per employee across its workforce of 2,725.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Astrana Health Inc. recorded 18.27M in income tax expense. That works out to an effective tax rate of 34.73, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 52.60M, leaving 35.49M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Astrana Health Inc.'s stock has gained approximately 19.72% over the past 52 weeks. The 50-day moving average sits at 32.66, while the 200-day moving average is 29.28.

Over the twelve months ended June 30, 2026, Astrana Health Inc. generated 3.36B in revenue and converted that into 35.49M in net income, yielding earnings per share of 0.74. EBITDA reached 143.09M, while operating income came in at 87.93M.

As of June 30, 2026, Astrana Health Inc. holds 350.81M in cash and equivalents against 857.28M in total debt, resulting in a net debt position of 468.90M. Total book value stands at 726.70M, with working capital of 150.13M providing operational flexibility.

Astrana Health Inc. produced 94.42M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -11.81M in capital expenditures, free cash flow totaled 82.61M - equivalent to 1.79 per share.

Over the twelve months ended June 30, 2026, Astrana Health Inc. posted a gross margin of 10.46, reflecting its pricing power and cost economics. The operating margin of 2.61 and net profit margin of 1.05 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Astrana Health Inc. paid dividends of 0.04 per share. The dividend payout ratio of 4.88 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 4.38, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -21.99, meaning Astrana Health Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Astrana Health Inc.'s most recent stock split took place on April 27, 2015 with a 10:1 split ratio.

As of June 30, 2026, Astrana Health Inc. has an Altman Z-Score of 5.03, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.